Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-EPI in Out-of-hospital Cardiac Arrest
NCT07442071Phase 3Not yet recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jun 2026
- Primary completion
- Jul 2030
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epinephrine in cardiac arrest (SCA), sponsored by CHRU de Nancy - Hôpital Central. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
epinephrine
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT07442071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07442071.